Hims to cut 4% of workforce amid ban on weight-loss drug copies

Hims to cut 4% of workforce amid ban on weight-loss drug copies#Hims #cut #workforce #ban #weightloss…

Report: Elon Musk’s drug use ramped up during the 2024 presidential campaign

Elon Musk reportedly increased his drug use during the 2024 presidential campaign in which he donated…

Cocrystal's flu drug shows promise against H5N1 strain

Cocrystal's flu drug shows promise against H5N1 strain#Cocrystal039s #flu #drug #shows #promise #H5N1 #strain

Veru Stock: Saving Muscle Mass Amidst The GLP-1 Drug Boom (NASDAQ:VERU)

This article was written by Follow Richard Prati has nearly 40 years of equity analysis and…

Is Novo Nordisk Immune To President Trump's Drug Price Plans

Is Novo Nordisk Immune To President Trump's Drug Price Plans #Novo #Nordisk #Immune #President #Trump039s #Drug…

Merus N.V.'s SWOT analysis: promising cancer drug pipeline boosts stock outlook

Merus N.V.'s SWOT analysis: promising cancer drug pipeline boosts stock outlook#Merus #N.V.039s #SWOT #analysis #promising #cancer…

Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug Testing

Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation…

UroGen Pharma: ODAC Decision Puts Drug Approval In Limbo, But It's Not Over, Either

UroGen Pharma: ODAC Decision Puts Drug Approval In Limbo, But It's Not Over, Either #UroGen #Pharma…

Eton Pharmaceuticals Set To Dominate Orphan Drug Niche (NASDAQ:ETON)

This article was written by Follow My handle is the Michigan Value Investor, but everyone calls…

US health authorities to set targets for lowering drug prices

US health authorities to set targets for lowering drug prices#health #authorities #set #targets #lowering #drug #prices

Pfizer signs up to $6 billion licensing deal with China's 3SBio for cancer drug

Pfizer signs up to $6 billion licensing deal with China's 3SBio for cancer drug#Pfizer #signs #billion…

Novo Nordisk CEO Exits Amid Obesity Drug Pressure

Novo Nordisk announced Friday that CEO Lars Fruergaard Jørgensen will step down, ending an eight-year tenure…

Incannex Healthcare Stock Soars on Sleep Apnea Drug Buzz

Whoa, folks, hold onto your hats! Incannex Healthcare Inc. (NASDAQ: IXHL) is lighting up the market…

Australia says it will not compromise on drug subsidies as Trump reviews US prices

Australia says it will not compromise on drug subsidies as Trump reviews US prices#Australia #compromise #drug…

Pharma stocks recover from initial shock of Trump's drug pricing order

Pharma stocks recover from initial shock of Trump's drug pricing order#Pharma #stocks #recover #initial #shock #Trump039s…

Asia pharma stocks tumble as Trump vows to slash US drug prices

Asia pharma stocks tumble as Trump vows to slash US drug prices#Asia #pharma #stocks #tumble #Trump…

Trump to sign executive order on reducing prescription drug prices

Trump to sign executive order on reducing prescription drug prices#Trump #sign #executive #order #reducing #prescription #drug…

J&J's skin disease drug meets main goal in late-stage study

J&J's skin disease drug meets main goal in late-stage study#JampJ039s #skin #disease #drug #meets #main #goal…

OpenAI and the FDA are reportedly discussing AI for drug evaluations

OpenAI has met with officials from the U.S. Food and Drug Administration (FDA) to discuss the…

Novo Nordisk cuts 2025 outlook as Wegovy obesity drug sales slow

Novo Nordisk cuts 2025 outlook as Wegovy obesity drug sales slow#Novo #Nordisk #cuts #outlook #Wegovy #obesity…

Cytokinetics stock falls on FDA delay for heart drug

Cytokinetics stock falls on FDA delay for heart drug#Cytokinetics #stock #falls #FDA #delay #heart #drug

Sonnet Chief Medical Officer, Richard Kenney, M.D., to Present at the 6th Annual Cytokine-Based Drug Development Summit

Sonnet Chief Medical Officer, Richard Kenney, M.D., to Present at the 6th Annual Cytokine-Based Drug Development…